Agilon Health (Agilon Health) Total Inventories : $0 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Agilon Health Total Inventories?

Agilon Health's total inventories for the quarter that ended in Dec. 2023 was $0 Mil. Agilon Health's average total inventories from the quarter that ended in Sep. 2023 to the quarter that ended in Dec. 2023 was $0 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Agilon Health's Net-Net Working Capital per share for the quarter that ended in Dec. 2023 was $0.29.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Agilon Health's Days Inventory for the three months ended in Dec. 2023 was 0.00.

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Agilon Health's Inventory-to-Revenue for the quarter that ended in Dec. 2023 was 0.00.

Agilon Health Total Inventories Historical Data

The historical data trend for Agilon Health's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Agilon Health Total Inventories Chart

Agilon Health Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Total Inventories

Agilon Health Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Total Inventories	Get a 7-Day Free Trial												-	-	-	-	-

Agilon Health Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.

Agilon Health (NYSE:AGL) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

Agilon Health's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2023 is

	Net-Net Working Capital Per Share (Q: Dec. 2023 )
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(488.343	+	0.75 * 942.461	+	0.5 * 0	-	1079.845
-	0	-	-0.818)	/	406.387
=	0.29

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Agilon Health's Days Inventory for the three months ended in Dec. 2023 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Dec. 2023 )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
	=	0	/	910.8	*	365 / 4
	=	0.00

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

Agilon Health's Inventory Turnover for the quarter that ended in Dec. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold (Q: Dec. 2023 )	/	Average Total Inventories (Q: Dec. 2023 )
	=	910.8	/	0
	=	N/A

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Agilon Health's Inventory to Revenue for the quarter that ended in Dec. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	0	/	815.504
	=	0.00

Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.

Agilon Health Total Inventories Related Terms

Thank you for viewing the detailed overview of Agilon Health's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.

Agilon Health (Agilon Health) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Agilon Health Inc (NYSE:AGL) » Definitions » Total Inventories

Comparable Companies

Traded in Other Exchanges

N/A

Address

6210 E. US Highway 290, Suite 450, Austin, TX, USA, 78723

Website

https://www.agilonhealth.com

Agilon Health Inc is transforming healthcare by empowering community-based physicians with the resources and expertise they need to innovate the payment and delivery of care for seniors. The company enables physicians to create their own Medicare-centric globally capitated line of business.

Executives

Jeffrey A. Schwaneke	director	C/O AGILON HEALTH, INC., 6210 E HWY 290, SUITE 450, AUSTIN TX 78723
Steven Sell	director, officer: CEO & President	C/O AGILON HEALTH, INC., 6210 E HWY 290, SUITE 450, AUSTIN TX 78723
Benjamin Shaker	officer: Chief Markets Officer	C/O AGILON HEALTH, INC., 6210 E HWY 290, SUITE 450, AUSTIN TX 78723
Timothy Gertsch	officer: Chief Accounting Officer	C/O AGILON HEALTH, INC., 6210 E HWY 290, SUITE 450, AUSTIN TX 78723
Silvana Battaglia	director	227 WASHINGTON STREET, CONSHOHOCKEN PA 19428
Cd&r Investment Associates Ix, Ltd.	10 percent owner	MAPLES CORPORATE SERVICES LIMITED, UGLAND HOUSE, GRAND CAYMAN E9 KY101194
Veeral Desai	officer: Chief Strategy & Dev. Officer	C/O AGILON HEALTH, INC., 6210 E HWY 290, SUITE 450, AUSTIN TX 78723
Benjamin Kornitzer	officer: Chief Med. & Quality Officer	C/O AGILON HEALTH, INC., 6210 E HWY 290, SUITE 450, AUSTIN TX 78723
John William Wulf	director	C/O AGILON HEALTH, INC., 6210 E HWY 290, SUITE 450, AUSTIN TX 78723
Diana Mckenzie	director	METLIFE, 200 PARK AVENUE, NEW YORK NY 10166
Priscilla Kasenchak	officer: Chief Accounting Officer	1111 MARCUS AVENUE, LAKE SUCCESS NY 11042
Michael L Smith	director	C/O AGILON HEALTH, INC., 6210 E HWY 290, SUITE 450, AUSTIN TX 78723
Theodore Halkias	officer: Chief Business Officer	C/O AGILON HEALTH, INC., 1 WORLD TRADE CENTER, SUITE 2000, LONG BEACH CA 90831
Joan Danieley	officer: Chief Administrative Officer	C/O AGILON HEALTH, INC., 1 WORLD TRADE CENTER, SUITE 2000, LONG BEACH CA 90831
Glenn Sobotka	officer: Chief Accounting Officer	C/O AGILON HEALTH, INC., 6210 E HWY 290, SUITE 450, AUSTIN TX 78723